Eli Lilly and Company (LLY)

337.66
-1.42(-0.42%)
After Hours
335.10
-2.56(-0.76%)
- Real-time Data
  • Volume:
    2,906,004
  • Day's Range:
    334.62 - 343.42
  • 52 wk Range:
    231.87 - 384.44

LLY Overview

Prev. Close
339.08
Day's Range
334.62-343.42
Revenue
21.24B
Open
341.98
52 wk Range
231.87-384.44
EPS
6.68
Volume
2,906,004
Market Cap
320.03B
Dividend (Yield)
4.52
(1.33%)
Average Vol. (3m)
2,911,966
P/E Ratio
50.46
Beta
0.353
1-Year Change
39.96%
Shares Outstanding
950,177,900
Next Earnings Date
Apr 27, 2023
What is your sentiment on Eli Lilly?
or
Market is currently closed. Voting is open during market hours.

Eli Lilly and Company News

Eli Lilly and Company Analysis

Eli Lilly and Company Company Profile

Eli Lilly and Company Company Profile

Employees
35000

Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.

Read More

Analyst Price Target

Average388.40 (+15.03% Upside)
High455.00
Low268.00
Price337.66
No. of Analysts22
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellBuy
Technical IndicatorsSellSellNeutralStrong SellStrong Buy
SummaryNeutralNeutralNeutralStrong SellStrong Buy
  • buy u fulz. going to 500
    0
    • shorting this trash
      2
      • damian delHow'd that work out for ya? lol
        0
      • Jimmy Doodoonever mind i can hold my short as long as i want, this trash will sink next year
        0
      • right shoulder a possibility now.
        0
    • how is this platform goes
      0
      • earning time ?
        0
        • My God what a monster of stock.
          0
          • 296
            0
            • This stock should get back to ASAP in 10 days
              1
              • Excellent company
                0
            • The U.S. FDA has granted Eli Lilly (LLY) and Boehringer Ingelheim's Jardiance Breakthrough Therapy designation as an investigational treatment for adults with heart failure with...
              0
              • https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
                0
                • 184 should be the bottom....
                  0
                  • 180?
                    0
                  • 10
                    0